Arrowhead Pharmaceuticals, Inc.

Connor, Clark & Lunn Investment Management Ltd. ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

663,262

Value ($000)

44,034

Weight

0.1%

2021 Q2 - 2025 Q4 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	44,034	0.1%	663,262	12/31/2025
2025 Q3	11/13/2025	4,295	0.0%	124,529	9/30/2025
2022 Q4	2/10/2023	703	0.0%	17,340	12/31/2022
2022 Q3	11/10/2022	1,548	0.0%	46,843	9/30/2022
2022 Q2	8/5/2022	3,056	0.0%	86,793	6/30/2022
2022 Q1	5/12/2022	3,057	0.0%	66,474	3/31/2022
2021 Q4	2/10/2022	2,114	0.0%	31,878	12/31/2021
2021 Q3	11/12/2021	4,142	0.0%	66,343	9/30/2021
2021 Q2	8/12/2021	2,896	0.0%	34,970	6/30/2021